Pro-GeneX, LLC

Pro-GeneX, LLC We help our clients, with help from their doctor's, to find the best medication match for them. This minimizes the risk of adverse drug reactions.

Final liquidation for lab equipment
05/08/2025

Final liquidation for lab equipment

10/27/2024

Not sure what drug she is on...

09/25/2024
Pro-GeneX has an ebay store for liquidating laboratory equipment... stop by and steal!
07/07/2024

Pro-GeneX has an ebay store for liquidating laboratory equipment... stop by and steal!

We are a group of laboratory professionals who acquire and redistribute quality medical devices, products, and disposables.

Address

The Advanced Technology Development Center At Georgia Tech, 75 5th Street Suite 200
Atlanta, GA
30308

Alerts

Be the first to know and let us send you an email when Pro-GeneX, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Pro-GeneX, LLC:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Personalized Medicine and Nutrition

Pro-GeneX is the leading firm in high-risk medication management in long term care in the United States, serving more than 34,000 patients. We have the first of its kind live data feed relationship with a major pharmacy provider which allows us to spot problems in real time. With that experience as our backbone. Pro-GeneX is now offering those same services to individuals, health plans, self-insured employment groups and PBMs, providing risk and cost reduction services. We spot medications that don’t work, and those that might cause harm. In the nutrition business we have a nutrigenomics panel that will inform our clients the right foods for them as well as the right exercise programs to maximize benefits of a healthy lifestyle. Finally, we have embarked on a program to deliver a gene panel to providers that gives genetic evidence of elevated addiction risks from opioids.